The Newest Addition To EMSCULPT NEO | The EDGE Applicators
Sleekly designed to allow for a better contour of the curvy areas of the body, such as the lateral abdomen, the Edge applicator utilizes radiofrequency and HIFEMTM technology to simultaneously address fat deposits and muscle groups in the lateral abdomen region.
Further, the new device extension tones the oblique muscles when treating the lateral abdomen, and many patients experience a significant improvement in their posture, core, and back discomfort.
EMSCULPT NEO builds off the legacy of its predecessor, EMSCULPT, by simultaneously emitting both radio frequency and high intensity electromagnetic energies.
The end result is more fat reduction and muscle growth, than any single gold standard product, for less time and less money.
60% of women and 90% of men are interested in one or both a fat reduction and muscle toning treatment.
EMSCULPT NEO is the first and only non-invasive body shaping procedure that provides simultaneous fat elimination and muscle building in a combined 30-minute session.
ONE In
Body ShapingEMSCULPT NEO is the only non-invasive technology that simultaneously uses Radiofrequency and HIFEM+ (high intensity electromagnetic field) to eliminate fat and build muscle. This results in more fat reduction and more muscle growth than any single gold standard product.
One Emsculpt treatment is the equivalent of
doing 20,000 crunches in 30 minutes.
The fat cells are slowly removed from the body and the strained muscle fibers initiate a growth process. This results in fat elimination and muscle building.
n less than 4 minutes the temperature in fat reaches levels that cause their permanent damage.
Muscles in the treated area are contracted at intensities that are not achievable during routine exercise.
The muscle temperature raises by several degrees, similar to what a warm-up activity does before any workout.
We’re here to answer any questions you may have and assist you in any way possible. Feel free to reach out to us using the following contact information:
